最高の女性のがん検診医師 - トップ71名の医師

ムスタファ・ソラク医師は、乳癌、精巣癌、卵巣癌、肺癌、頭頸部癌、および消化器腫瘍を専門とする腫瘍内科医です。ハジェッテペ大学医学部を卒業後、シシリ・エトファル・イスタンブール研修研究病院で研修医課程を修了し、その後ハジェッテペ大学腫瘍研究所でフェローシップ研修を行いました。

ソラク医師は数多くの複雑な腫瘍症例を担当してまいりました。テキサス大学MDアンダーソンがんセンターをはじめとする主要施設において、臨床腫瘍学の発展に貢献しました。また、チョルムのヒッティト大学附属病院およびメディカルパーク病院においても診療に従事しました。その豊富な経験は、癌の治療と研究に対する深い献身を示しています。

職歴

• 2006年5月 – 2007年10月：ウルギュップ国立病院（産科婦人科における義務従事）
• 2008年7月 – 2009年7月：エドレミット軍病院（軍務）
• 2009年11月 – 2015年4月：アダナ・バシュケント大学病院、産科婦人科
• 2015年5月 – 2018年5月：マルマラ大学、婦人科腫瘍学レジデンシープログラム
• 2018年7月 – 2024年9月：ウムラニエ教育研究病院
• 2024年12月 – 現在：アナドル医療センター

海外診療経験

• 2009年8月 – 2009年11月：シバ・テル・ハショメル医療センター、イスラエル
• 2014年7月：アスクレピオスクリニック、ハンブルク、ドイツ
• 2018年2月 – 2018年3月：シャリテ病院、ベルリン、ドイツ

学歴

• 医学博士研究員：マルマラ大学、婦人科腫瘍学部門、2015年－2018年、イスタンブール
• 医学専門研修：バシュケント大学医学部、産科婦人科、2001年－2006年、アンカラ
• 医学部：イスタンブール大学チェッラーパシャ医学部、1994年－2000年、イスタンブール

専門分野

• 婦人科腫瘍学における外科治療、およびその他の基本的・高度な婦人科手術。妊孕性温存手術、腹腔鏡手術、ロボット支援手術に特に精通している。

学会・団体所属

• ESGO – 欧州婦人科腫瘍学会（2015年より会員）
• TRSGO – トルコ婦人科腫瘍学会（2016年より会員）

教授 医学博士 メフメット・カラジャ

生年：1971年、

出生地：アンタルヤ。

外国語能力：英語

診療分野 腫瘍センター 学歴・研修 産婦人科学教授

診療分野 婦人科腫瘍疾患 妊娠 ハイリスク妊娠 腹腔鏡手術 泌尿器婦人科学 性器審美外科 不妊症 体外受精

学歴・研修

1993年 – アクデニズ大学医学部卒業（学士）。

1993年 — アクデニズ大学医学修士号取得、1999年 — ディジレ大学産婦人科学博士号取得。

2011年 - 婦人科小腫瘍外科における保健省研修

2002年 - 2005年 - ガジアンテップ大学医学部 - 講師

2006年 - 2010年 - カフカス大学医学部 - 講師

2010年 - 2014年 - アンタルヤ教育研究病院 - 科長

2014年 – 2021年 – メドスター・ユルドゥズ病院

2018年 - 2021年 - ゲリシム大学講師

2021年 - 現在 - メディカルパーク・アンタルヤ病院群

オフェル・メリムスキー教授は、骨腫瘍・軟部腫瘍・中皮腫・肺癌・肝臓および肺への転移性病変を専門とする著名な腫瘍内科医です。スラスキー医療センター（イヒロフ、テルアビブ）の骨格・軟部腫瘍科の科長を務め、イスラエル臨床腫瘍医協会の会長を兼任しています。

主な専門領域と患者様へのメリット：

• 豊富な臨床経験と国際的な診療実績として、米国・フランス・イスラエルでの研修歴およびエルサレム大学での教育活動が挙げられ、高精度の先進的診断・治療法の提供が可能です。
• 腫瘍科的治療法には、肉腫・中皮腫・骨格および軟部腫瘍の治療のほか、放射線療法および小線源治療が含まれます。希少かつ難治性の腫瘍疾患に対しても、患者様は包括的な治療を受けることができます。
• 権威ある学術誌への多数の論文掲載実績として、New England Journal of Medicine（N Engl J Med）、Annals of Oncology、および欧州臨床腫瘍学会（European Society for Medical Oncology、ESMO）関連誌への発表があり、患者様が最新かつエビデンスに基づいた治療法を受けられることを保証しています。
• 国際学術団体への加盟として、Society of Oncologists and Radiotherapists Israel、ASCO、EMSOS、CTOSへの所属が、その高い専門性を証明するとともに、最新の治療プロトコルへのアクセスを可能にしています。
• オンライン診療を通じた遠隔診察・助言の提供が可能であり、世界どこからでも専門家による医療支援を受けることができます。

患者様はメリムスキー教授の深い腫瘍学的知識、個別化された治療計画の立案能力、そして細やかな対応を高く評価しており、治療の全過程を通じて安心感と信頼感が得られると好評です。

1.Bachelor’s degree
- Doctor of medicine, Rangsit university.

2.Master’s degree

>Medical and health science degree
- Professional master’s degree in clinical nutrition in medicine.
- Professional master’s degree in integrative medicine.

>Management degree
- Professional master’s degree in hospital and health services management.

3.Doctorate degree
- Doctorate in psychology (candidate).

4.Diploma
- American Bord of nutritional wellness.
- American naturopathic certification board.

- Certified integrative oncology physician, American institute of integrative oncology.

- Certified fertility wellness physician.

- Certified CBT-I physician.

- Advanced nutritional wellness, IFNW.

-Biochemical and clinical analysis diploma.

- Functional gastroenterology and pediatric food allergies diploma.

- IV nutrition diploma, IFNW.

-Medicinal herbology diploma, IFNW.

Education and Specialization

• Faculty of Medicine, Hacettepe University
• 1999 - Akdeniz University, Faculty of Internal Medicine, Internal Medicine Specialization Training
• Internal Medicine Specialization Training in the USA, Akdeniz University (2013 - 2014)
• Internal Medicine Specialization Training in the USA (2013 - 2014) - Medical Oncology Department
• Akdeniz University, Faculty of Medicine, Department of Medical Oncology (Received Associate Professorship title)

Work Experience

• 2009 - Kayseri Training and Research Hospital, Hospital
• Acıbadem Kayseri
• 2017 - 2018 - Lara Private Anadolu Hospital
• 2018 - Medical Park Antalya Hospital Complex

Expertise

• Diagnosis of organ tumors
• Chemotherapy in cancer treatment
• Targeted cancer therapies
• Immunotherapy in cancer treatment
• Next-generation genetic research in cancer treatment
• Complementary medicine in cancer treatment
• Medical oncology

医学博士マヌエラ・ザイフェルト — ゾーリンゲン学術病院（ドイツ）乳腺科・乳房外科部長。患者様が自然な外見と自信を保てるよう支援しています。

資格と患者様へのメリット：

• 乳房温存手術を実施し、女性患者様が日常生活に早期復帰できるよう取り組んでいます。
• デュッセルドルフのハインリヒ・ハイネ大学を卒業し、博士号を取得 — 正確な診断と効果的な治療を提供しています。
• ヴッパータールの主要病院で10年以上、上級医師として勤務し、豊富な臨床経験を積んでいます。
• ドイツ乳腺学会、DEGUM、およびドイツ産婦人科医師連合の会員 — 最新の国際診療基準を診療に取り入れています。
• 包括的なアプローチを採用：外科的治療に加え、回復促進と精神的サポートを目的として、心理療法・運動療法・自然療法を推奨しています。

患者様は、その細やかな配慮、複雑な治療方針をわかりやすく説明する能力、そして困難な局面における精神的サポートを高く評価しています。これにより、患者様は安心して治療を受け、治療結果に確信を持つことができます。

Dr. Asawadech Sanbua

Medical Radiation​ Oncologist

• Passed palliative care training at the Karunrak Center. Khon Kaen University
  
   
• Certificate of oncotherm
  
   
• Expert in treating cancer with oncothermia machines (or hyperthermia machine) 5 years experience.
  
   
• 14 years of experience working in radiotherapy. Able to plan treatment (Planning 2D, 3D, IMRT, VMAT)
  
   
• Can provide chemical treatment, Chemotherapy, targeted drugs therapy) Immunotherapy (Immunotherapy) 

• Education:
•  
• 1992- 1998: Middle School - Lyceum of Neapolis, Lassithi, Crete, Greece
• 1999- 2004: Department of Physiotherapy, “Alexander” University of Thessaloniki, Greece
• 2004 - 2010: School of Medicine, University of Crete, Greece
• 2007: Laboratory of Molecular Genetics, Boston University, USA.
• 2010: Department of Mental Health, “Ospedale Maggiore”, Bologna, Italy
• 2017 – 2019: Master of Public Health, EUC, Cyprus
• 2019 – 2023: Doctor of Philosophy (PhD), School of Medicine, University of Crete, Greece

Professional Experience:

• 2010: Medical license
• 2011 - 2012: Rural doctor, Chandras, Crete, Greece
• 2012 - 2017: Resident in Internal Medicine, Department of Internal Medicine, University Hospital of Heraklion, Greece
• 2016: Fellowship at the 1st Department of Internal Medicine, “Konstantopouleio” General Hospital of Nea Ionia, Greece
• 2016: Fellowship at the Infectious Diseases Unit, “Attikon” General Hospital, Greece
• 2017: Specialty degree in Internal Medicine
• 2017. Fellowship at the Infectious Diseases Unit, University Hospital of Heraklion, Greece
• 2017 - 2018. Attending physician, Department of Internal Medicine, University Hospital of Heraklion, Greece
• 2018 - 2020: Specialization in Infectious Diseases, University Hospital of Heraklion and “Attiko” University Hospital of Athens, Greece
• 2020 - 2021: Research Associate, Infectious Diseases Unit, University Hospital of Heraklion, Greece
• 2021: Specialist degree in Infectious Diseases

Memberships:

• Hellenic Society of Infectious Diseases
• Cypriot Society of Clinical Microbiology and Infectious Diseases
• European Society of Clinical Microbiology and Infectious Diseases
• Faculty member of the European Committee on Infection Control (EUCIC)
• Faculty member of the ESCMID Study Group for Antimicrobial Stewardship (ESGAP)
• Board member of the Greek Medical Society for Infectious Diseases in Obstetrics and Gynaecology
• Country Manager of Cyprus of the International Society for Infectious Diseases in Obstetrics and Gynaecology (ISIDOG)

Awards:

• Pancretan Association of the U.S.A. scholarship, 2007: training in Molecular Genetics, Boston University, USA.
• Hellenic AIDS Study scholarship for specialization in Infectious Diseases, 2018 - 2019, Greece
• 2018 – 2024: Representative of Greece as Infectious Disease Specialist in the Trainee Association of ESCMID (TAA) of the European Society for Clinical Microbiology and Infectious Diseases

Academic Experience:

• 2016-2019: Internal Medicine A, 3rd year of undergraduate studies at School of Medicine of Crete, Greece
• 2017-2021: Internal Medicine B, 4th year of undergraduate studies at School of Medicine of Crete, Greece
• 2018-2022: MSc Programme "Public Health & Healthcare Facilities Administration", School of Medicine of Crete, Greece
• 2021: MSc Programme “Emergency and Intensive Care”, School of Medicine, University of Crete, Greece
• 2022-2024: MSc Programme “Public Health”, School of Medicine, University of Patras, Greece
• 2022-2024: MSc Programme “Prevention and Control of clinically severe infections in the Healthcare setting”, School of Medicine, University of Thessaly, Greece

Research Activities:

• 2007: Use of adenoviruses as gene therapy vectors, laboratory researcher, Boston, USA.
• 2018: "Overcome" clinical trial, study co-coordinator, Heraklion, Greece.
• 2019: "REDS" clinical trial, study coordinator, Heraklion, Greece.
• 2019: "Entasis" clinical trial, study coordinator, Heraklion, Greece
• 2019 - 2020: "Rationalizing the use of antibiotics in patients hospitalized at a University Hospital”, principal investigator, University Hospital of Heraklion, Heraklion, Greece

Personal Information 

Sex:  Male

Born : 1968 

Professional Experience

Gayrettepe Florence Nigthingale Hospital

Medical Oncology Department

Besiktas/Istanbul/Turkey (ongoing)

Education:

He became Professor (22/April /2016)

Medical Oncology

Attending Phys.in Gastrointestinal Oncology (January 2005 ,2009)

Istanbul University Oncology Institue,

Department of Medical Oncology

Medical Oncology Fellowship (December 2001-December2004)

Istanbul University, Istanbul Medical Faculty

Hemodialysis Traning (May1996-January1997)

Istanbul University ,bCerrahpasa Medical Faculty

Internal Medicine Residency (November 1991-November 1996)

Istanbul University ,bCerrahpasa Medical Faculty

Ege University Medical Faculty (1985-1991)

Professional Experience

February 1999-November 2001

Metropolitan Florence Nigthingale Hospital

American Cancer Center, Gayrettepe/İstanbul

April1997- October 1998

Bayraktar Dialysis Center

Güngören/ Istanbul

Membership

Turkish Medical Oncology Association

ENET(European Neuroendocrine Tumour Society)

ESMO

ASCO

2023 – Istanbul Gaziosmanpaşa Taksim Education and Research Hospital – General Surgery Clinic Associate Professor

2013 – Istanbul Gaziosmanpaşa Taksim Education and Research Hospital – General Surgery Clinic Specialist

2008 – 2013 Private Medical Park Fatih Hospital, General Surgery Specialist - Deputy Chief Physician

2005 – 2007 Private Gelişim Hospital – General Surgery Specialist

2003 – 2005 Private Istanbul Şafak Hospital – General Surgery Specialist - Chief Physician

2002 – 2003 ISTANBUL HASEKİ EDUCATION AND RESEARCH HOSPITAL – General Surgery Clinic Assistant Physician

1998 – 2002 Ankara Education and Research Hospital – General Surgery Clinic Assistant Physician

1998 – Health Sciences University – Istanbul Haseki Health Application and Research Center – Medical Specialization

1991 – Gazi University Faculty of Medicine – Bachelor’s Degree

Certificates

IGM Diagnosis, Treatment Workshop, Granulomatous Mastitis, Kocaeli, Certificate, 07.10.2023 (National)

ibreast 51- Free Flap Reconstruction, Breast Cancer Surgery, Online, Certificate, 30.09.2023 – 30.09.2023 (International)

ibreast 50- Triple Negative Breast Cancer, Breast Cancer, Online, Certificate, 02.09.2023 -02.09.2023 (International)

ibreast 49- Implant Based Reconstruction, Breast Cancer, Online, Certificate, 12.08.2023 -12.08.2023 (International)

ibreast 48- DCIS, İbreast 48- DCIS, Online, Certificate, 15.07.2023 -15.07.2023 (International)

ibreast 47- Conference Updates, Breast Cancer, Online, Certificate, 25.06.2023 -25.06.2023 (International)

ibreast 46- Margin Revisited, Breast Cancer, Online, Certificate, 10.06.2023 -10.06.2023 (International)

1. International 4. National Breast Surgery Congress, Breast Surgery, Ürgüp, Certificate, 05.05.2023 – 07.05.2023 (International)

ibreast 44- HER2 Positive Disease, Breast Cancer, Online, Certificate, 29.04.2023 -29.04.2023 (International)

St-Gallen 2023, St-Gallen Congress Summary Meeting, Istanbul, Certificate, 01.04.2023 -01.04.2023 (National)

ibreast 43- Save The Nipple, Breast Cancer, Online, Certificate, 25.03.2023 -25.03.2023 (International)

ibreast 42-Chest Wall Perforator Flap Revisited, Breast Cancer, Online, Certificate, 25.02.2023 -25.02.2023 (International)

ibreast 41- High Risk And B3 Lesions, Breast Diseases, Online, Certificate, 28.01.2023 -28.01.2023 (International)

15. New Approaches in Breast Cancer Education Meeting, Breast Cancer, Istanbul, Certificate, 07.01.2023 – 08.01.2023 (National)

Articles she wrote and took part in;

1.YILDIRIM EMİNE, BEKTAŞ SİBEL, YETİŞ FIRAT, YILDIZ EREN OZAN, ÖZDEMİR MUHAMMED, KOMUT NESLİHAN, ÇALIK MUSTAFA, ER AHMET MUZAFFER. Correlation between breast and axillary pathologic complete response after neoadjuvant chemotherapy in breast cancer. Annali Italiani di Chirurgia, 2023

2.UZUN NEDİM, YILDIRIM EMİNE. Relationship Between Toilet Type and Hemorrhoids. Bezmialem Vakif University, 2022

3.YILDIZ EREN OZAN, YILDIRIM EMİNE, ORHUN ERDOĞAN KIVILCIM, ERYILMAZ İKLİL, YÜNLÜEL EMİR MEHMET, YETİŞ FIRAT, ULUKENT SUAT CAN. The effect of the covid 19 pandemic on the number of patients treated for acute and complex acute appendicitis. Annali Italiani di Chirurgia, 2202

4.YILDIRIM EMİNE, BEKTAŞ SİBEL, ÖZDEMİR MUHAMMED, KARAGÜLLE AHENK, ER AHMET MUZAFFER, UÇAR NEŞE. Upgrade Rates of DCIS, Intraductal Papilloma, and the Other High-risk Breast Lesions. Hamidiye Medical Journal, 2022
 

5.ÖZKAN GÜMÜŞKAYA PERİHAN, ALTUN ÖZGÜR, KARAKÜTÜK YÜZTAŞ NUR, ÖZSOY NESLİHAN, AYDIN TUTAK GÜLTEN, YILDIRIM EMİNE, ADAŞ MİNE, KÜÇÜK MEHMET. COVID-19 Pnömonisi Sonrası AntiHBs Değerlerindeki Değişiklikler. Journal of Contemporary Medicine, 2022;12(4), 

6.KOMUT NESLİHAN, BEKTAŞ SİBEL, YILDIRIM EMİNE. The relationship of tumor budding with GOLPH3 expression and histopathological prognostic parameters in colorectal adenocarcinoma. Annals of Diagnostic Pathology 2022 Jun;58:151933. 

7.KAYADİBİ YASEMİN, UÇAR NEŞE, AKAN YEŞİM NAMDAR, KAYA MEHMET FATİH, YILDIRIM EMİNE, ALADAĞ KURT SEDA, SOYLU BOY FATMA NUR, TAŞKIN FÜSUN, İÇTEN GÜL ESEN. Magnetic resonance imaging findings associated with recurrence in idiopathic granulomatous mastitis. Clinical Imaging, 2022

8.YILDIRIM EMİNE, KEĞİN MURAT, ÖZDEMİR MUHAMMED, BEKTAŞ SİBEL, PELEN ZEKERİYA, ER AHMET MUZAFFER. Neoplasms of theAppendix; Single Institution and Ten-Year Experiences Results. Turkish Journal of Trauma and Emergency Surgery, 2022;28(3), 352-360

9.YILDIRIM EMİNE, YILDIZ EREN OZAN, ERYILMAZ İKLİL, ER AHMET MUZAFFER, BEKTAŞ SİBEL. Comparison of excised breast volume, re-excision rate and margin positivity in breast-conserving surgery in breast cancer patients using and not using neoadjuvant chemotherapy. Journal of Surgery in Medicine,2022;6

10.YILDIRIM EMİNE, BEKTAŞ SİBEL, PELEN ZEKERİYA, YANIK İREM, ER AHMET MUZAFFER, ÇENGEL FERHAT, ÖZKAN GÜMÜŞKAYA PERİHAN. Histopathological, Radiological, and Demographic Factors Predicting the Response to Neoadjuvant Therapy for Rectal Cancer. Journal of Gastrointestinal Cancer, 2022;53(1)

11.KAYADİBİ YASEMİN, KOÇAK BURAK, UÇAR NEŞE, AKAN YEŞİM NAMDAR, YILDIRIM EMİNE, BEKTAŞ SİBEL. MRI Radiomics of Breast Cancer: Machine Learning-Based Prediction of Lymphovascular Invasion Status. Academic Radiology, 2022;29(1), 126-134.

12.YILDIRIM EMİNE, UÇAR NEŞE, YETİŞ FIRAT, KAYADİBİ YASEMİN, BEKTAŞ SİBEL. Diagnostic performance of breast imaging with ultrasonography, magnetic resonance and mammography in the assessment of residual tumor after neoadjuvant chemotherapy in breast cancer patients. Journal of Surgery and Medicine, 2022;6(1), 43-48

13.YILDIRIM EMİNE, BEKTAŞ SİBEL, GÖKTAŞ AYDIN SABİN, ER AHMET MUZAFFER, YANIK İREM, ÖZKAN GÜMÜŞKAYA PERİHAN, YILMAZ BARBAROS UTKU, BİLİCİ AHMET, ÖNCEL MUSTAFA. Factors Predicting Response to Neoadjuvant Chemotherapy in Locally Advanced Gastric Cancer. Journal of Istanbul Faculty of Medicine / İstanbul Tıp Fakültesi Dergisi, 2022;85(1), 41-50. 

14.YILDIRIM EMİNE, Pelen Zekeriya, KEĞİN MURAT, UÇAR NEŞE, KAYADİBİ YASEMİN, GÜNDOĞAR ÖZGECAN. Evaluation of the Reliability of Preoperative Ultrasonography and Ultrasonography-Guided Fine Needle Aspiration Biopsy in Axillary Staging in Patients With Breast Cancer. Journal of Academic Research in Medicine, 2021;11(3), 269-276., 

15. KAYADİBİ YASEMİN, UÇAR NEŞE, KAYA MEHMET FATİH, YILDIRIM EMİNE, BEKTAŞ SİBEL. Characterization of Suspicious Microcalcifications on Mammography Using 2D Shear-Wave Elastography. Ultrasound in Medicine & Biology, 2022;47(9), 2532-2542. 

16.KAYADİBİ YASEMİN, TEKCAN ŞANLI DENİZ ESİN, UÇAR NEŞE, YILDIRIM EMİNE, ŞANLI AHMET NECATİ. Evaluation of the Appearance Characteristics of Suspicious Microcalcifications Detected by Ultrasonography. Journal of Academic Research in Medicine, 2022;11(2), 199-205. 

17.YILDIRIM EMİNE, ÖZER HİLAL, ÖZER İLTER, KOYUNCU ADİL, YILDIRIM TİMUR. The Effects on Bacterial Translocation and Tissue Damage of Selenium Treatment in an Experimental Intestinal Ischaemia-Reperfusion Model. Turkish Journal of Trauma and Emergency Surgery, 2021;27(4), 389-394. 

18.YILDIRIM EMİNE, AKBAŞ PELİN, ORHUN ERDOĞAN KIVILCIM, BEKTAŞ SİBEL, ÖZKAN GÜMÜŞKAYA PERİHAN, ER AHMET MUZAFFER, PALTURA CEKİ. The comparison of the histopathological results of the thyroid fine-needle aspiration biopsies in the 795 patients with thyroidectomy. Diagnostic Cytopathology, 2021

Experience

2022 PRIVATE MEDIPOL BAHÇELİEVLER HOSPITAL

2021 - 2021 Prof. Dr. Cemil Taşçıoğlu City Hospital, Medical Oncology Clinic Education Officer

2021 - 2021 Prof. Dr. Cemil Taşçıoğlu City Hospital

2020 - 2021 Yüzüncü Yıl University Faculty of Medicine

2020 - 2021 Head of the Department of Medical Oncology, Yüzüncü Yıl University Faculty of Medicine, Assoc. Dr.  

2018 - 2021 Lecturer - Yüzüncü Yıl University Faculty of Medicine, Head of Medical Oncology Department  

2018 - 2021 Yüzüncü Yıl University Faculty of Medicine

2015 - 2018 University of Health Sciences, Okmeydanı Training and Research Hospital

2015 - 2018 University of Health Sciences, Okmeydanı Training and Research Hospital, Medical Oncology Clinic, Sub-branch assistant

2012 - 2015 Kanuni Sultan Süleyman Training and Research Hospital, Internal Medicine specialist

2012 - 2015 Suleiman the Magnificent Training and Research Hospital,

2008 - 2012 Haseki Training and Research Hospital

2006 - 2008 Kızıltepe No. 3 Health Center General Practitioner.

Education

2018

İstanbul Okmeydanı Eğitim ve Araştırma Hastanesi, Tıbbı Onkoloji

2018

İstanbul Okmeydanı Eğitim ve Araştırma Hastanesi, Tıbbı Onkoloji, İstanbul Okmeydanı Eğitim ve Araştırma Hastanesi, Tıbbı Onkoloji

2012

İstanbul Haseki Eğitim ve Araştırma Hastanesi, İç Hastalıkları, İstanbul Haseki Eğitim ve Araştırma Hastanesi, İç Hastalıkları

2012

İstanbul Haseki Eğitim ve Araştırma Hastanesi, İç Hastalıkları

2007

Uludağ Üniversitesi Tıip Fakültesi, Tıip Fakültesi, Uludağ Üniversitesi Tıip Fakültesi, Tıip Fakültesi

Activities • Prevention, research and early diagnosis of cancer • Palliative care in cancer • Cytotoxic chemotherapy • Hormontherapy • Targeted treatment • Immunotherapy Education • 2004 -2010 - Istanbul University, Istanbul faculty of medicine • 2011-2015 - Istanbul University, Istanbul faculty of medicine, internal medicine specialist • 2013-2014 - Cleveland Clinic Endocrinology Department, research associate • 2016-2019 Bezmiâlem Foundation University Medical Oncology Subdivision • Dissertation: Prognostic value of absolute monocyte count in patients with mantle cell lymphoma. • Subdivision Dissertation: An effect of adjuvant chemotherapy on lipid profile and anthropometric parameters in patients with breast and colon cancer. Publications • Circulating Thyroid-Stimulating Hormone Receptor Messenger RNA as a Marker of Tumor Aggressiveness in Patients with Papillary Thyroid Microcarcinoma. Aliyev A, Gupta M, et al. Endocr  18. • The utility of peripheral thyrotropin receptor mRNA in the management of differentiated thyroid cancer. • Aliyev A, Soundararajan S, Bucak E et al. Surgery.  • Diagnostic accuracy of circulating thyrotropin receptor messenger RNA combined with neck ultrasonography in patients with Bethesda III-V thyroid cytology. Aliyev A, Patel J, Brainard J, et al. Surgery.2016 Jan;159(1):113-7. doi: 10.1016/j.surg.2015.06.063. Epub 2015 Oct 9. • Role of Urotensin-2 in 5-Fluorouracil-Related Arterial Vasoconstriction in Cancer Patients. Seker M, Aliyev A, et al. Oncol Res Treat. Epub 2018 Aug 20. • Pertuzumab, trastuzumab and taxane-based treatment for visceral organ metastatic, trastuzumab-naive breast cancer: real-life practice outcomes. Esin E, Oksuzoglu B, Bilici A, Aliyev A. Cancer Chemother Pharmacol.2019 Jan; Epub 2018 Oct 30. • Usefulness of serum M30 and M65 levels to predict response to neoadjuvant chemotherapy in patients with breast cancer. Turk HM, Aliyev A, Celik RS. Curr Probl Cancer.2019 Jul 29. pii: currproblcancer.2019.06.009. • Prognostic impact of primary tumor location on survival in metastatic colorectal cancer patients: A single center experience. Tarik Demir, Murat Araz, Altay Aliyev. Medicine Science International Medicine Journal. • Oral presentations 

Personal information

Title: Professor Doctor

Branch: Radiation Oncology

Work History:

1 GATA Military Medical Faculty

2 Gayrettepe Florence Nightingale Hospital

3 T.R. Demiroğlu Bilim University \ Associate Professor

4 T.R Demiroğlu Bilim University \ Professor

Medical Specialties and Subspecialties:

1 Head and Neck Cancers

2 Radiation Oncology

Priority treatments:

1 Prostate cancer

2 Conformal treatments

Special advanced health technologies:

1 Truebeam Stx Technology

2 Halcyons

Education

1991 - Istanbul University Istanbul Faculty of Medicine

1996 - Istanbul University Cerrahpaşa Faculty of Medicine Radiation

Oncology Specialization Training

Education:  Azerbaijan Medical University, Pediatrics, 2003-2009, Pediatrician  Ministry of Justice of the Republic of Azerbaijan, Intern, 2009-2010, Anesthesiologistreanimatologist (Intensive Therapy) Work experience:  Liv Bona Dea International Hospital, Emergency Physician June 2019 – present  International SOS (GIM) / BP AGT Caspian Sea "Shah Deniz Bravo" Project, Azerbaijan, Caspian Sea, Field doctor February 2017-November 2019  Azerbaijan National Anti-Doping Agency (AMADA), Azerbaijan, Baku, Doping Control Inspector June 2017  4th Islamic Solidarity Games, Azerbaijan, Baku, Medical consultant of Heydar Aliyev arena, May 2017  International SOS (GIM) / BP AGT Caspian Sea “Deepwater Gunashli” Project, Azerbaijan, Caspian Sea, Field Doctor January 2015 – January 2017  International SOS (GIM), Azerbaijan, Baku, site coordinator April 2014-December 2014  Doctor at the Central Neftchilar Hospital, Baku, Azerbaijan, Reanimation and Intensive Therapy Department (trial period) April-September 2012  Premium Assist Insurance Company, Azerbaijan, Baku, Chief Medical Expert (Night shift) AprilSeptember 2012  Medical intern at the Department of Anesthesiology and Intensive Therapy in various institutions under the Ministry of Justice of the Republic of Azerbaijan, Baku, Azerbaijan, August 2009- July 2010  Medi Club Clinic, Azerbaijan, Baku, Physician Assistant/Emergency paramedic August 2007 – July 2010 

Dr. Akif Nuri Doğan is an internal medicine specialist. He graduated from Cerrahpaşa School of Medicine, Istanbul University in 2002. He completed his residency at Bezm-i Alem Vakıf Gureba Teaching and Research Hospital in 2008.

He works at Hisar Hospital Intercontinental. He provides assessment, diagnosis, and treatment for internal diseases. His main areas of focus are obesity, reflux, hypertension, diabetes, and chronic fatigue.

Dr. Doğan has gained experience at Elazig Military Hospital, Antalya Training and Research Hospital, and Akseki State Hospital. He is known for his evidence-based approach and dedication to patient care.